NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









TIBEAY Biosciences

TIBEAY Biosciences

Private
NijmegenHealthcare & Life Scienceshttps://tibeay-biosciences.com/

Last Round

VC Round

Apr 15, 2026

Momentum

Top 10%

of companies Caplight tracks

Company Overview

TIBEAY Biosciences is a biotechnology company that develops therapies for acute neurological conditions, such as its lead substance Ronopterin, which is designed to reduce secondary brain damage in patients with severe traumatic brain injury.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Clinical Trials, Drug Discovery

Business Model

B2B

Customer Profile

Government Contracts, Revenue Share

AI Layer

Non-AI

Keywords

traumatic brain injuryTBIclinical-stage biotechneurotherapeuticssecondary brain injuryiNOS inhibitorfirst-in-class therapysmall molecule drugneuroprotectiondrug developmentCNS drug developmentacute neurological diseasePhase 3 trial

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

TIBEAY Biosciences Comps

Public and private peers based on sector, stage, and business model.

TIBEAY Biosciences comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

TIBEAY Biosciences Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundApr 15, 2026

TIBEAY Biosciences Investors

Notable investors and investment history

TIBEAY Biosciences investors
InvestorRounds
MIG AGVC Round
Athos KGVC Round
MeneldorVC Round
East Netherlands Development Agency (Oost NL)VC Round

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 15, 2026

    $41M round led by Athos KG

TIBEAY Biosciences Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

TIBEAY Biosciences Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about TIBEAY Biosciences's valuation, stock price, and market status.

Firmographic Details

HeadquartersNijmegen
Employee Range7
Year FoundedN/A
Last FundingApr 15, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.